Hepatitis B vaccine development and implementation

Hepatitis C Virus and Vaccine Development

The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generating new vaccines or drugs is an obligation. However, there is no vaccine available for clinical u...

Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy

Objective (s):The aim of this study was to determine the correlation between vaccine therapy and appearance of mutations in hepatitis B surface antigen (HBsAg)-positive chronic hepatitis B virus (HBV) patients. Materials and Methods: 16 patients received the HBV vaccine and another 16 individuals from the control group did not. The surface gene was amplified and directly sequenced from samples...

Hepatitis B vaccine.

Many Vaccine Information Statements are available in Spanish and other languages. See www.immunize.org/vis. 1 What is hepatitis B? Hepatitis B is a serious disease that affects the liver. It is caused by the hepatitis B virus (HBV). HBV can cause: Acute (short-term) illness. This can lead to: • loss of appetite • diarrhea and vomiting • tiredness • jaundice (yellow skin or eyes) • pain in muscl...

Hepatitis B vaccine immunogenicity in Kerman 12 months infants

Introduction: Infection  with  HBV  is  the  most  common  chronic  viral  infection  and mortality  in  children.  Prevention of this infection with vaccination is vital.  This  study  was  done  to compare  the  antibody  level  in post hepatitis  B vaccination  in  children  with  12 months  age. Materials  and  Methods:This  descriptive  study  was  carreid  out  on healthy  120  children  ...

can Isolated hepatitis B core antibody in HIV-infected patients response to hepatitis B vaccine help to elucidate the cause?